Your browser doesn't support javascript.
loading
The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia.
Demyanets, Svitlana; Jaeger, Eva; Pablik, Eleonore; Greiner, Georg; Herndlhofer, Susanne; Valent, Peter; Schwarzinger, Ilse.
Afiliación
  • Demyanets S; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Jaeger E; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Pablik E; Centre for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Greiner G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Herndlhofer S; Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Valent P; Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Schwarzinger I; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
Br J Haematol ; 181(1): 137-139, 2018 04.
Article en En | MEDLINE | ID: mdl-28220937

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Células Madre Neoplásicas / Leucemia Mielógena Crónica BCR-ABL Positiva / Janus Quinasa 2 / Proteínas de Neoplasias Límite: Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Células Madre Neoplásicas / Leucemia Mielógena Crónica BCR-ABL Positiva / Janus Quinasa 2 / Proteínas de Neoplasias Límite: Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Austria